The case for semi-mandatory HPV vaccination in China

Nat Biotechnol. 2013 Jul;31(7):590-1. doi: 10.1038/nbt.2631.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • China
  • Female
  • Human papillomavirus 16 / drug effects
  • Human papillomavirus 16 / pathogenicity
  • Human papillomavirus 18 / drug effects
  • Human papillomavirus 18 / pathogenicity
  • Humans
  • Papillomavirus Vaccines / administration & dosage*
  • Uterine Cervical Neoplasms / mortality
  • Uterine Cervical Neoplasms / prevention & control*

Substances

  • Papillomavirus Vaccines